HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Franco Locatelli Selected Research
Franco Locatelli Research Topics
Disease
143
Neoplasms (Cancer)
05/2024 - 05/2002
82
Leukemia
01/2024 - 10/2002
80
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024 - 07/2002
56
Graft vs Host Disease (Graft-Versus-Host Disease)
10/2023 - 05/2002
40
Infections
01/2024 - 12/2002
34
Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 05/2002
27
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 02/2003
23
Neuroblastoma
03/2024 - 03/2011
22
COVID-19
01/2023 - 01/2020
18
Thalassemia
12/2023 - 06/2002
17
Residual Neoplasm
12/2023 - 08/2005
17
beta-Thalassemia (Cooley's Anemia)
01/2023 - 06/2002
13
Bronchiolitis Obliterans Syndrome
07/2023 - 08/2002
12
Aplastic Anemia (Anemia, Hypoplastic)
04/2024 - 09/2004
12
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
11/2023 - 06/2005
12
Juvenile Myelomonocytic Leukemia
01/2021 - 04/2004
11
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2024 - 06/2002
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2024 - 04/2012
10
Disease Progression
11/2023 - 05/2002
9
Cytomegalovirus Infections (Inclusion Disease)
01/2024 - 04/2005
9
Lymphoma (Lymphomas)
12/2023 - 09/2004
9
Glioma (Gliomas)
09/2023 - 01/2005
9
Inflammation (Inflammations)
05/2023 - 06/2007
9
Acute Promyelocytic Leukemia
01/2023 - 01/2004
8
Sarcoma (Soft Tissue Sarcoma)
01/2024 - 06/2006
8
Sickle Cell Anemia (Hemoglobin S Disease)
10/2023 - 03/2003
8
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 04/2003
7
Glioblastoma (Glioblastoma Multiforme)
02/2024 - 01/2015
7
Medulloblastoma
01/2023 - 01/2016
7
Cytokine Release Syndrome
01/2023 - 01/2019
7
Fanconi Anemia (Fanconi's Anemia)
01/2021 - 09/2007
7
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2019 - 04/2002
6
Brain Neoplasms (Brain Tumor)
04/2024 - 07/2013
6
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2023 - 08/2003
6
Rhabdomyosarcoma
01/2023 - 09/2011
6
Hodgkin Disease (Hodgkin's Disease)
01/2022 - 01/2016
5
Carcinogenesis
04/2024 - 05/2012
5
Hemorrhage
01/2023 - 07/2005
5
Bone Marrow Failure Disorders
11/2022 - 09/2007
5
Diffuse Intrinsic Pontine Glioma
01/2022 - 05/2017
5
Neutropenia
07/2019 - 12/2002
4
Communicable Diseases (Infectious Diseases)
01/2024 - 02/2012
4
Hematologic Diseases (Blood Diseases)
12/2023 - 07/2008
4
Cytopenia
11/2023 - 04/2014
4
Lymphopenia (Lymphocytopenia)
01/2023 - 01/2019
4
Philadelphia Chromosome
01/2023 - 02/2010
4
Autoimmune Diseases (Autoimmune Disease)
01/2022 - 09/2009
Drug/Important Bio-Agent (IBA)
24
Proteins (Proteins, Gene)
FDA Link
11/2022 - 08/2005
20
blinatumomab
IBA
05/2023 - 12/2016
20
Ligands
IBA
01/2023 - 08/2003
17
Antigens
IBA
12/2023 - 02/2000
16
Cytokines
IBA
05/2023 - 06/2007
15
Chimeric Antigen Receptors
IBA
11/2023 - 12/2013
15
Biomarkers (Surrogate Marker)
IBA
11/2022 - 04/2005
13
fludarabine
IBA
10/2023 - 11/2002
12
Steroids
IBA
07/2023 - 01/2007
12
Antibodies
IBA
01/2023 - 07/2009
12
MicroRNAs (MicroRNA)
IBA
01/2019 - 09/2011
10
Monoclonal Antibodies
IBA
01/2021 - 02/2002
9
Cyclosporine (Ciclosporin)
FDA Link
Generic
04/2024 - 05/2002
9
treosulfan
IBA
01/2024 - 07/2012
9
Messenger RNA (mRNA)
IBA
11/2023 - 06/2003
9
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2023 - 01/2006
9
DNA (Deoxyribonucleic Acid)
IBA
11/2023 - 04/2002
9
Enzymes
IBA
05/2023 - 02/2012
9
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2021 - 08/2008
8
Vaccines
IBA
11/2022 - 10/2013
7
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
04/2024 - 08/2003
7
Busulfan (Busulfex)
FDA Link
01/2024 - 02/2014
7
Antiviral Agents (Antivirals)
IBA
01/2021 - 06/2003
7
KIR Receptors
IBA
01/2016 - 03/2009
6
Neoplasm Antigens (Tumor Antigens)
IBA
12/2023 - 05/2004
6
ruxolitinib
IBA
07/2023 - 09/2016
6
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2023 - 01/2004
6
Immunoglobulins (Immunoglobulin)
IBA
05/2022 - 04/2008
6
Inosine Triphosphate (ITP)
IBA
01/2022 - 04/2003
6
Interferons
IBA
01/2021 - 10/2004
6
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2020 - 06/2002
6
Rituximab (Mabthera)
FDA Link
01/2020 - 02/2002
6
Prednisone (Sone)
FDA Link
Generic
02/2016 - 07/2002
5
Inotuzumab Ozogamicin
IBA
01/2024 - 01/2021
5
Emapalumab
IBA
11/2023 - 11/2019
5
Etoposide (VP 16)
FDA Link
Generic
11/2022 - 03/2011
5
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
05/2022 - 01/2016
5
dipinacoline glutamate
IBA
01/2022 - 05/2017
5
immune RNA (I-RNA)
IBA
01/2022 - 02/2012
5
Imatinib Mesylate (Gleevec)
FDA Link
01/2021 - 03/2006
4
Azacitidine (5 Azacytidine)
FDA Link
03/2024 - 02/2015
Therapy/Procedure
131
Therapeutics
05/2024 - 04/2002
129
Hematopoietic Stem Cell Transplantation
03/2024 - 05/2002
80
Transplantation
10/2023 - 05/2002
49
Drug Therapy (Chemotherapy)
05/2024 - 10/2002
40
Stem Cell Transplantation
10/2023 - 05/2002
30
Immunotherapy
10/2023 - 03/2011
15
Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2013 - 06/2002
6
Cell Transplantation
01/2020 - 03/2009
5
Combined Modality Therapy
03/2024 - 01/2020
5
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022 - 12/2005
4
Haploidentical Transplantation
09/2023 - 10/2014
4
Splenectomy
11/2022 - 10/2013